you would think that NAB are backing the chance of a higher bid, buying right up until the ex div date. Surely there are better divs to chase if that was all they were after.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025